Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Gynecology · Uterine Fibroids

Can Asymptomatic Uterine Fibroids Be Safely Left Untreated?

At a Glance

Asymptomatic uterine fibroids that look typical can often be managed with watchful waiting rather than immediate treatment. There is no universal ultrasound schedule; follow-up depends on symptoms, age, fertility plans, and imaging, while new bleeding, pain, or pressure should prompt reassessment.

Finding out you have an incidentally discovered fibroid can be unsettling, but if your fibroids are not causing you problems, it is usually safe to observe them rather than treat them immediately. This approach is called expectant management or watchful waiting. It is an active plan—not simply ignoring the condition—that involves paying close attention to your body and reviewing symptoms with your doctor. Medical guidelines generally do not recommend treatment (such as surgery or a hysterectomy) simply because a typical, benign-appearing asymptomatic fibroid is present [1] [2].

What Monitoring Looks Like

There is no strict, universal schedule (such as every 6 or 12 months) for routine ultrasound monitoring of typical asymptomatic fibroids [3] [4]. In fact, many clinicians monitor based on your symptoms and do not order regular follow-up scans at all. An individualized monitoring plan may include a symptom review, a physical exam when appropriate, and repeat imaging only if clinically indicated. Follow-up is tailored based on several key factors [1] [5]:

  • Your age and life stage: Fibroids are sensitive to hormones and often shrink on their own after menopause [5] [6]. If you are in perimenopause (the transitional years leading up to menopause), observation is a common choice. However, approaching menopause does not eliminate the need to evaluate any new bleeding, pain, or changes in your health.
  • Fertility goals: If you plan to become pregnant, preconception counseling is recommended. Your care team will want to document the fibroid’s location and whether it distorts the uterine cavity (the inside of the womb where a pregnancy grows). Fibroids that push into the cavity, known as submucosal fibroids, may affect implantation and pregnancy [7] [8]. While fibroids within the uterine muscle (intramural) or on the outer surface (subserosal) generally have less effect, their size and number can still matter, so individualized advice is key.
  • Initial imaging findings: If your initial ultrasound clearly shows a typical fibroid, less intensive monitoring is needed. However, if the imaging is unclear or the fibroid looks atypical, your doctor may suggest a follow-up ultrasound or an MRI (Magnetic Resonance Imaging). An MRI can help characterize the mass and guide next steps, though it cannot definitively rule out all rare conditions on its own [9] [10] [11].

When to Contact Your Doctor for Reassessment

Watchful waiting relies on agreed-upon triggers for reassessment. You should contact your clinician for evaluation if you develop new symptoms, rather than waiting for your next scheduled appointment [3] [12] [13]. Warning signs that warrant a fresh evaluation include:

  • New or heavy bleeding: Periods that become heavier, last longer, or occur irregularly [3] [14].
  • Signs of anemia: Feeling unusually fatigued, dizzy, or weak. Your doctor may order a blood count and check your iron levels, as this can be a sign of iron-deficiency anemia caused by unnoticed heavy menstrual bleeding [12] [1] [14].
  • Pelvic pain or pressure: New aching, cramping, or a feeling of persistent heaviness in your pelvis [3].
  • Bulk symptoms: Needing to urinate frequently, having difficulty emptying your bladder, or developing new constipation. These issues can happen if a growing fibroid takes up space and presses on nearby bowel or bladder organs [5] [1].
  • Changes after menopause: Any new bleeding after 12 months without a period should be promptly assessed. Likewise, if imaging shows a newly enlarging uterine mass after menopause, it requires prompt evaluation. While rapid growth by itself does not prove cancer, it must be thoroughly investigated to rule out other, more serious conditions [2] [15] [16].

When to Seek Urgent Care

While most fibroid symptoms develop gradually, some situations require immediate attention. Seek urgent emergency care if you experience:

  • Extremely heavy bleeding, such as soaking through one pad or tampon per hour for two or more consecutive hours [3] [12].
  • Heavy bleeding accompanied by faintness, shortness of breath, chest pain, or marked weakness [12] [17].
  • Sudden, severe pelvic pain, fever, vomiting, or a sudden inability to urinate [3] [5].

Common questions in this guide

Can asymptomatic uterine fibroids be left untreated?
Often, yes. If a fibroid has typical benign features and is not causing symptoms, clinicians commonly choose watchful waiting instead of immediate surgery or hysterectomy. The plan should include clear symptoms or changes that would trigger reassessment.
How often should an asymptomatic uterine fibroid be checked?
There is no single follow-up schedule that applies to everyone, and routine ultrasound every 6 or 12 months is not universally needed. Many clinicians use symptom-based follow-up and repeat imaging only when symptoms develop, the original scan is unclear, or a person’s age, fertility plans, or findings call for closer review.
What symptoms should make me contact my doctor sooner?
Contact your clinician if bleeding becomes heavier, lasts longer, or becomes irregular, or if you develop pelvic pain or pressure. Fatigue, dizziness, weakness, frequent urination, trouble emptying your bladder, or new constipation can also warrant reassessment.
Can fibroids that do not cause symptoms affect pregnancy?
They can, depending on their location, size, and number. Fibroids that grow into the uterine cavity, called submucosal fibroids, may affect implantation, while intramural or subserosal fibroids generally have less effect. If you plan to become pregnant, ask about preconception counseling.
Do uterine fibroids need evaluation after menopause?
New bleeding after 12 months without a period should be assessed promptly. A newly enlarging uterine mass after menopause also needs evaluation; growth alone does not prove cancer, but clinicians must investigate other possible causes.
When should fibroid-related bleeding or pain be treated as an emergency?
Seek emergency care for bleeding that soaks through at least one pad or tampon per hour for two or more hours, especially with faintness, shortness of breath, chest pain, or marked weakness. Sudden severe pelvic pain, fever, vomiting, or inability to urinate also requires urgent attention.
Can an MRI clarify an atypical fibroid seen on ultrasound?
MRI can provide more detail about a uterine mass and help guide next steps when an ultrasound is unclear or atypical. It cannot by itself definitively rule out every rare condition, so your clinician will interpret it alongside your symptoms and other findings.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on uterine corpus leiomyoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How large are my fibroids, and exactly where are they located (e.g., submucosal, intramural, subserosal)?
  2. 2.Based on my age and symptom history, what specific follow-up schedule or monitoring plan do you recommend for me?
  3. 3.Do any of my fibroids distort my uterine cavity, or should I see a fertility specialist if I plan to become pregnant?
  4. 4.What specific symptoms or changes should prompt me to contact you for reassessment before my next scheduled visit?
  5. 5.If my fibroid appears atypical on ultrasound, would an MRI help clarify the diagnosis?

References

References (17)
  1. 1

    The management of uterine leiomyomas.

    Vilos GA, Allaire C, Laberge PY, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2015; (37(2)):157-178 doi:10.1016/S1701-2163(15)30338-8.

    PMID: 25767949
  2. 2

    The management of uterine leiomyomas.

    Lefebvre G, Vilos G, Allaire C, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2003; (25(5)):396-418; quiz 419-22.

    PMID: 12738981
  3. 3

    Guideline No. 461: The Management of Uterine Fibroids.

    Chen I, Kives S, Randle E, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2025; (47(8)):102970 doi:10.1016/j.jogc.2025.102970.

    PMID: 40562356
  4. 4

    Current medical treatment of uterine fibroids.

    Sohn GS, Cho S, Kim YM, et al.

    Obstetrics & gynecology science 2018; (61(2)):192-201 doi:10.5468/ogs.2018.61.2.192.

    PMID: 29564309
  5. 5

    Uterine Fibroids: Diagnosis and Treatment.

    De La Cruz MS, Buchanan EM

    American family physician 2017; (95(2)):100-107.

    PMID: 28084714
  6. 6

    New treatment options for nonsurgical management of uterine fibroids.

    Lee S, Stewart EA

    Current opinion in obstetrics & gynecology 2023; (35(4)):288-293 doi:10.1097/GCO.0000000000000880.

    PMID: 37144584
  7. 7

    Impact of fibroids on fertility, pregnancy loss, and preconception management.

    Ezike O, Schneyer R, Wright K, Hamilton K

    Current opinion in obstetrics & gynecology 2025; (37(4)):207-214 doi:10.1097/GCO.0000000000001033.

    PMID: 40299726
  8. 8

    The effect of myomectomy on reproductive outcomes in patients with uterine fibroids: A retrospective cohort study.

    Don EE, Mijatovic V, van Eekelen R, Huirne JAF

    Reproductive biomedicine online 2022; (45(5)):970-978 doi:10.1016/j.rbmo.2022.05.025.

    PMID: 36041962
  9. 9

    Clinical signs and diagnosis of fibroids from adolescence to menopause.

    Mension E, Carmona F, Vannuccini S, Chapron C

    Fertility and sterility 2024; (122(1)):12-19 doi:10.1016/j.fertnstert.2024.05.003.

    PMID: 38729337
  10. 10

    Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification.

    Awiwi MO, Badawy M, Shaaban AM, et al.

    Abdominal radiology (New York) 2022; (47(7)):2468-2485 doi:10.1007/s00261-022-03545-x.

    PMID: 35554629
  11. 11

    The utility of MRI for the preoperative differential diagnosis of uterine sarcoma and leiomyoma: a single-center study.

    Yazawa H, Yazawa R, Anjo K, et al.

    Fukushima journal of medical science 2024; (70(4)):211-218 doi:10.5387/fms.23-00018.

    PMID: 39370272
  12. 12

    Guideline No. 389-Medical Management of Symptomatic Uterine Leiomyomas - An Addendum.

    Laberge PY, Murji A, Vilos GA, et al.

    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2019; (41(10)):1521-1524 doi:10.1016/j.jogc.2019.01.010.

    PMID: 31548041
  13. 13

    The Lublin Protocol of the Uterine Arteries Embolization in the Treatment of Symptomatic Uterine Fibroids.

    Szkodziak P, Pyra K, Szkodziak F, et al.

    Journal of visualized experiments : JoVE 2020; doi:10.3791/61530.

    PMID: 33016950
  14. 14

    Perimenopausal abnormal uterine bleeding.

    Dreisler E, Frandsen CS, Ulrich L

    Maturitas 2024; (184()):107944 doi:10.1016/j.maturitas.2024.107944.

    PMID: 38412750
  15. 15

    Rapidly growing uterine myoma - should we be afraid of it?

    Nowak M, Bartosik W, Witana W, et al.

    Przeglad menopauzalny = Menopause review 2023; (22(3)):161-164 doi:10.5114/pm.2023.131497.

    PMID: 37829270
  16. 16

    Development and Validation of a Nomogram to Predict the Risk of Special Uterine Leiomyoma Pathological Types or Leiomyosarcoma in Postmenopausal Women: A Retrospective Study.

    Wang Y, Zhao Y, Shi C, et al.

    Risk management and healthcare policy 2024; (17()):1669-1685 doi:10.2147/RMHP.S461773.

    PMID: 38919406
  17. 17

    The impact of anemia on treatment management and clinical outcomes of women hospitalized for uterine leiomyomas.

    Antunes D, Gante I, Carvalho MJ, et al.

    Ginekologia polska 2022; (93(10)):799-805 doi:10.5603/GP.a2022.0086.

    PMID: 36196563

This page explains watchful waiting for asymptomatic uterine fibroids for informational purposes only and does not constitute medical advice. A gynecologist can help interpret your findings and set a monitoring plan for your situation.